Ruby Lieshout

2.2k total citations
11 papers, 311 citations indexed

About

Ruby Lieshout is a scholar working on Surgery, Hepatology and Cancer Research. According to data from OpenAlex, Ruby Lieshout has authored 11 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 5 papers in Hepatology and 4 papers in Cancer Research. Recurrent topics in Ruby Lieshout's work include Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Liver physiology and pathology (4 papers) and Tissue Engineering and Regenerative Medicine (2 papers). Ruby Lieshout is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Liver physiology and pathology (4 papers) and Tissue Engineering and Regenerative Medicine (2 papers). Ruby Lieshout collaborates with scholars based in Netherlands, Germany and Spain. Ruby Lieshout's co-authors include Monique M.A. Verstegen, Luc J. W. van der Laan, Jorke Willemse, Jaap Kwekkeboom, Dave Sprengers, Guoying Zhou, Maikel P. Peppelenbosch, Martin E. van Royen, Gilles van Tienderen and Ling Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hepatology and British Journal of Cancer.

In The Last Decade

Ruby Lieshout

11 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruby Lieshout Netherlands	10	128	116	90	79	76	11	311
Qungang Shan China	13	59 0.5×	70 0.6×	83 0.9×	153 1.9×	62 0.8×	24	432
Tian‐Run Lv China	8	104 0.8×	140 1.2×	89 1.0×	37 0.5×	62 0.8×	35	316
Kunsong Zhang China	9	89 0.7×	77 0.7×	161 1.8×	31 0.4×	65 0.9×	19	335
Xi Ai China	10	90 0.7×	59 0.5×	163 1.8×	101 1.3×	18 0.2×	24	361
Kevin P. Labadie United States	7	136 1.1×	36 0.3×	61 0.7×	57 0.7×	66 0.9×	15	292
Toshihide Muramatsu Japan	10	186 1.5×	106 0.9×	153 1.7×	93 1.2×	64 0.8×	10	396
Guangyan Lei China	9	79 0.6×	77 0.7×	108 1.2×	15 0.2×	80 1.1×	20	290
Jiangjiao Zhou China	13	113 0.9×	109 0.9×	55 0.6×	118 1.5×	48 0.6×	23	359
Zhengyan Zhu China	10	157 1.2×	33 0.3×	109 1.2×	80 1.0×	45 0.6×	20	375
Mohammed Alnaggar China	9	237 1.9×	57 0.5×	83 0.9×	29 0.4×	48 0.6×	16	444

Countries citing papers authored by Ruby Lieshout

Since Specialization

Citations

This map shows the geographic impact of Ruby Lieshout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby Lieshout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby Lieshout more than expected).

Fields of papers citing papers by Ruby Lieshout

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruby Lieshout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby Lieshout. The network helps show where Ruby Lieshout may publish in the future.

Co-authorship network of co-authors of Ruby Lieshout

This figure shows the co-authorship network connecting the top 25 collaborators of Ruby Lieshout. A scholar is included among the top collaborators of Ruby Lieshout based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruby Lieshout. Ruby Lieshout is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Lieshout, Ruby, Alessandra Valéria de Sousa Faria, Maikel P. Peppelenbosch, et al.. (2022). Kinome profiling of cholangiocarcinoma organoids reveals potential druggable targets that hold promise for treatment stratification. Molecular Medicine. 28(1). 74–74. 10 indexed citations

Zhou, Guoying, Ruby Lieshout, Gilles van Tienderen, et al.. (2022). Modelling immune cytotoxicity for cholangiocarcinoma with tumour-derived organoids and effector T cells. British Journal of Cancer. 127(4). 649–660. 63 indexed citations

Tienderen, Gilles van, Oskar Rosmark, Ruby Lieshout, et al.. (2022). Extracellular matrix drives tumor organoids toward desmoplastic matrix deposition and mesenchymal transition. Acta Biomaterialia. 158. 115–131. 36 indexed citations

Lieshout, Ruby, Monique M.A. Verstegen, Michail Doukas, et al.. (2022). Cholangiocarcinoma cell proliferation is enhanced in primary sclerosing cholangitis: A role for IL‐17A. International Journal of Cancer. 152(12). 2607–2614. 10 indexed citations

Koch, Michael, Ruby Lieshout, Luc J. W. van der Laan, et al.. (2022). Label-Free Imaging Analysis of Patient-Derived Cholangiocarcinoma Organoids after Sorafenib Treatment. Cells. 11(22). 3613–3613. 12 indexed citations

Nguyen, Luan, Myrthe Jager, Ruby Lieshout, et al.. (2021). Precancerous liver diseases do not cause increased mutagenesis in liver stem cells. Communications Biology. 4(1). 1301–1301. 9 indexed citations

Roos, Floris J.M., Haoyu Wu, Jorke Willemse, et al.. (2021). Cholangiocyte organoids from human bile retain a local phenotype and can repopulate bile ducts in vitro. SHILAP Revista de lepidopterología. 11(12). e566–e566. 27 indexed citations

Liu, Jiaye, Pengfei Li, Ling Wang, et al.. (2020). Modelling liver tumor organoids and cancer-associated fibroblasts interaction reveals the robust effects of stromal niche in cancer nurturing and treatment resistance. Journal of Hepatology. 73. S638–S639. 1 indexed citations

Li, Meng, Ling Wang, Yijin Wang, et al.. (2020). Mitochondrial Fusion Via OPA1 and MFN1 Supports Liver Tumor Cell Metabolism and Growth. Cells. 9(1). 121–121. 81 indexed citations

10.

Vicent, Silvestre, Ruby Lieshout, Anna Saborowski, et al.. (2019). Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma. Liver International. 39(S1). 79–97. 27 indexed citations

11.

Willemse, Jorke, Ruby Lieshout, Luc J. W. van der Laan, & Monique M.A. Verstegen. (2017). From organoids to organs: Bioengineering liver grafts from hepatic stem cells and matrix. Best Practice & Research Clinical Gastroenterology. 31(2). 151–159. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact